Nevro Corp
NYSE:NVRO
Relative Value
The Relative Value of one
NVRO
stock under the Base Case scenario is
8.87
USD.
Compared to the current market price of 5.84 USD,
Nevro Corp
is
Undervalued by 34%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
NVRO Competitors Multiples
Nevro Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Nevro Corp
NYSE:NVRO
|
220.9m USD | 0.5 | -1.9 | -2.3 | -2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
188.4B USD | 4.3 | 28.9 | 16.5 | 22.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
169.6B USD | 16.9 | 59.4 | 45 | 55.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
132.3B USD | 5.3 | 40.7 | 20.8 | 25.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.9B USD | 3.2 | 24.3 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.7B USD | 5.3 | 36.5 | 21.4 | 28.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42B EUR | 1.8 | 19.9 | 11.2 | 15.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48B USD | 7.9 | 44.7 | 24.6 | 26.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46B USD | 10.7 | 43.4 | 30.8 | 34.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45B USD | 2.1 | 25.6 | 10.1 | 17.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.2B USD | 6.1 | 22.3 | 15.7 | 17.4 |